Can Gabapentin Cause Dry Eye?
Gabapentin does not cause dry eye syndrome; in fact, emerging evidence suggests it may be therapeutic for dry eye disease, particularly when neuropathic ocular pain is present. 1
Evidence from FDA Drug Labeling
The official FDA labeling for gabapentin does not list dry eye as an adverse effect. 1 The documented ocular side effects in clinical trials include:
- Amblyopia (blurred vision): 3-4% in postherpetic neuralgia trials and epilepsy trials 1
- Diplopia (double vision): 1-6% depending on indication 1
- Conjunctivitis: 1% in postherpetic neuralgia trials 1
- Nystagmus: 8% in epilepsy patients 1
Notably absent from this comprehensive list of adverse reactions is any mention of dry eye, decreased tear production, or related ocular surface symptoms. 1
Therapeutic Role in Dry Eye Disease
Contrary to causing dry eye, recent research demonstrates that gabapentin may actually treat dry eye disease, particularly when neuropathic pain is a component:
Oral Gabapentin for Neuropathic Ocular Pain
- Patients with severe dry eye and neuropathic pain features showed significantly improved outcomes when gabapentin was added to standard artificial tears and cyclosporine treatment compared to topical therapy alone (p < 0.001). 2
- Improvements were seen in OSDI scores, Schirmer's test results, and tear break-up time after 6 weeks of treatment. 2
- Gabapentin appears most effective in patients with systemic comorbidities and less pain evoked by mechanical/chemical stimuli. 3
Topical Gabapentin Effects
- Topical gabapentin eye drops demonstrate analgesic properties without anesthetic effects, meaning they relieve pain without blocking the neural feedback necessary for tear production. 4
- Unexpectedly, topical gabapentin stimulates lacrimation through upregulation of acetylcholine, norepinephrine, and aquaporin 5 (AQP5) expression in lacrimal glands. 4
- This secretagogue effect helps restore the tear film and reduces ocular surface friction. 4
Mechanism-Based Benefits
Gabapentin provides multiple therapeutic mechanisms relevant to dry eye:
- Anti-inflammatory properties through NF-kB inhibition 5
- Analgesic effects via calcium channel modulation 5
- Stimulation of tear production rather than suppression 4
- Treatment of neuropathic ocular pain component often present in moderate-to-severe dry eye 6, 7
Clinical Implications
If a patient on gabapentin reports dry eye symptoms, the gabapentin is not the cause. 1 Instead, clinicians should:
- Evaluate for other contributing factors (environmental, other medications, underlying autoimmune conditions) 8
- Consider that the patient may have pre-existing dry eye disease that could potentially benefit from the gabapentin 2, 3
- Screen for neuropathic ocular pain features using tools like the painDETECT questionnaire if dry eye symptoms are refractory to standard treatment 2
Common Pitfall to Avoid
Do not discontinue gabapentin based on a mistaken belief that it causes dry eye. The medication is not associated with this adverse effect in FDA-approved labeling or clinical trials, and emerging evidence suggests potential therapeutic benefit for dry eye patients with neuropathic pain components. 1, 2, 3, 4